Search

Nvidia (NVDA) was the poster child of the first two years of the bull market, running up a staggering 1,100%. Could this AI stock be the heir apparent?

There’s no “cheat code” for the stock market, but following this one number will give you a ton of insight into where it might be headed next.

Although the market has been stalled for most of 2025, the resiliency is truly impressive. Here are two ways to trade this up-in-the-air market.

Cannabis investors need to practice patience while they wait for the next major sector catalyst, but they’re on the horizon on both the state and federal levels.

The cannabis sector’s “shadow lenders” offer rich yields to buoy the portfolios of cannabis investors should Trump’s “promises made” fall flat.

We always prefer to go with the evidence, but it’s also useful to have a plan of attack, and these big-picture lessons can help you trade smarter in 2025.

For the second straight week growth stocks got hit hard, which weighed on the Nasdaq. Though interestingly, as money rotated out of the 2024 leaders, it raced into slow and steady stocks that have been left behind in years past. By week’s end the S&P 500 had lost 1%, the Dow had gained 1%, and the Nasdaq had fallen 3.5%.

For the second straight week growth stocks got hit hard, which weighed on the Nasdaq. Though interestingly as money rotated out of the 2024 leaders, it raced into slow and steady stocks that have been left behind in years past. By week’s end the S&P 500 had lost 1%, the Dow had gained 1%, and the Nasdaq had fallen 3.5%.

For the second straight week growth stocks got hit hard, which weighed on the Nasdaq. Though interestingly as money rotated out of the 2024 leaders, it raced into slow and steady stocks that have been left behind in years past. By week’s end the S&P 500 had lost 1%, the Dow had gained 1%, and the Nasdaq had fallen 3.5%.

As I mentioned in this week’s update, CEG has some technical support around the $225 per share range. The stock had been flying high but has been under considerable pressure recently. CEG (currently around $227 per share) is down over 35% from the high made in late January.

Take Profit in Starbucks (SBUX); Sell American Airlines (AAL)

Please sell our Recursion Pharmaceuticals (RXRX) recommendation, as after a strong start the stock has pulled back sharply.

The newly implemented tariffs are expected to hamper economic growth and company earnings, but these three stock picks may actually benefit.

WHAT TO DO NOW: Remain defensive as the ferocious selling in growth stocks continues. Today’s bulletin concerns Duolingo (DUOL), which reported a fine quarter and better-than-expected outlook—but the stock is cracking nevertheless. We’ll cut bait here, leaving us with around 72% in cash.

The selloff in leading stocks that started last week has continued, and now it’s spilled over into the major indexes, as it usually does—most indexes were down 2% or more on the week, including the Nasdaq down 5% and many growth measures off 4%-plus.

After a strong start to the year, February was a down month for the S&P 500. The index is just a little over 1% higher YTD. But the news is better than it may seem.

Sure, the market has been struggling. But it’s only because of technology, which is down over 5% YTD. Nine of the other ten sectors in the S&P are positive for the year. Some sectors are having very good years as Health Care is up over 8% and Consumer Staples and Financials are up over 7% YTD.

Sell Astera Labs (ALAB) and Cellebrite (CLBT)